Retinal Biologics Market Revenue 2024 to 2034
Retinal Biologics Market Revenue 2024 to 2034
The global retinal biologics market size is anticipated to grow from USD 27 billion in 2025 to USD 53.61 billion by 2034, with a compound annual growth rate (CAGR) of 7.92% during the forecast period from 2025 to 2034.
Report ID: 10245
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 25.02 Bn
Forecast Year,
USD USD 53.61 Bn
CAGR, 2025 -
7.92%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Retinal Biologics Market Size Analysis
Retinal Biologics Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VEGF-A Antagonist | 18.83 | 20.35 | 22.01 | 23.77 | 25.67 | 27.58 | 29.68 | 32.07 | 34.75 | 37.48 | 40.52 |
| TNF-A Inhibitor | 6.19 | 6.65 | 7.13 | 7.68 | 8.26 | 9.05 | 9.85 | 10.59 | 11.29 | 12.20 | 13.10 |
Retinal Biologics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Macular Degeneration | 11.37 | 12.34 | 13.40 | 14.38 | 15.61 | 16.77 | 18.25 | 19.94 | 21.46 | 23.31 | 24.97 |
| Diabetic Retinopathy | 6.25 | 6.64 | 7.09 | 7.74 | 8.40 | 9.12 | 9.77 | 10.31 | 11.16 | 11.90 | 13.14 |
| Uveitis | 3.70 | 4.00 | 4.31 | 4.60 | 4.93 | 5.30 | 5.68 | 6.16 | 6.60 | 7.10 | 7.60 |
| Others | 3.70 | 4.03 | 4.34 | 4.73 | 5.00 | 5.44 | 5.83 | 6.25 | 6.82 | 7.37 | 7.91 |
Retinal Biologics Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 13.60 | 14.71 | 15.76 | 17.03 | 18.19 | 19.60 | 21.18 | 22.88 | 24.77 | 26.56 | 28.63 |
| Retail Pharmacies | 6.32 | 6.78 | 7.49 | 8.12 | 8.87 | 9.48 | 10.12 | 10.93 | 11.91 | 12.93 | 13.89 |
| Online Pharmacies | 5.10 | 5.51 | 5.88 | 6.30 | 6.88 | 7.55 | 8.23 | 8.85 | 9.35 | 10.19 | 11.09 |
Retinal Biologics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 9.95 | 10.79 | 11.54 | 12.36 | 13.21 | 14.12 | 15.12 | 16.44 | 17.56 | 19.07 | 20.49 |
| Asia Pacific | 6.26 | 6.77 | 7.33 | 8.01 | 8.57 | 9.31 | 10.11 | 10.80 | 11.93 | 12.73 | 14.01 |
| Europe | 5.56 | 5.96 | 6.53 | 7.01 | 7.73 | 8.40 | 9.10 | 9.80 | 10.52 | 11.43 | 12.12 |
| Latin America | 1.74 | 1.85 | 1.98 | 2.17 | 2.39 | 2.60 | 2.83 | 3.10 | 3.34 | 3.58 | 3.92 |
| Middle East and Africa | 1.51 | 1.62 | 1.76 | 1.90 | 2.04 | 2.18 | 2.37 | 2.51 | 2.69 | 2.87 | 3.08 |
Retinal Biologics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
